opioid dependence phenotype
Evidence from:
primary |
all sources
Related entities (40)
Mentioned in (17)
Papers in which this entity is mentioned.
- Mapping the genetic landscape across 14 psychiatric disorders. (2026)
- Alcohol use disorder is associated with altered frontomedial phase-amplitude coupling strength during resting state. (2026)
- Clinical, genomic, and neurophysiological correlates of lifetime suicide attempts among individuals with alcohol dependence. (2024)
- Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder. (2024)
- Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users. (2023)
- Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. (2022)
- Association Between Benzodiazepine or Z-Drug Prescriptions and Drug-Related Poisonings Among Patients Receiving Buprenorphine Maintenance: A Case-Crossover Analysis. (2021)
- Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction. (2021)
- Genome-wide association study identifies a novel locus for cannabis dependence. (2018)
- Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks. (2016)
- KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex. (2016)
- Polygenic risk for alcohol dependence associates with alcohol consumption, cognitive function and social deprivation in a population-based cohort. (2016)
- Genomewide Association Study for Maximum Number of Alcoholic Drinks in European Americans and African Americans. (2015)
- Genome-wide association study of nicotine dependence in American populations: identification of novel risk loci in both African-Americans and European-Americans. (2015)
- Genome-wide association study of cocaine dependence and related traits: FAM53B identified as a risk gene. (2014)
- Genomic regions identified by overlapping clusters of nominally-positive SNPs from genome-wide studies of alcohol and illegal substance dependence. (2011)
- Obesity, smoking, and frontal brain dysfunction. (2010)
Merged raw entities (22)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| opioid dependence | phenotype | 39 | 139 |
| opioid use disorder | phenotype | 18 | 63 |
| opioid addiction | phenotype | 11 | 40 |
| opiate dependence | phenotype | 10 | 13 |
| opioid abuse | phenotype | 5 | 10 |
| opioid analgesic dependence | phenotype | 2 | 2 |
| opioid-dependent | phenotype | 2 | 3 |
| opioid use disorders | phenotype | 2 | 2 |
| long-term opioid dependence | phenotype | 1 | 1 |
| opioid analgesic dependent | phenotype | 1 | 1 |
| opioid dependent | phenotype | 1 | 2 |
| addiction to opioids | phenotype | — | — |
| addictive properties of drugs | phenotype | — | — |
| dsm‑iv od | phenotype | — | — |
| opiate | phenotype | — | — |
| opiate dependent subjects | phenotype | — | — |
| opioid-addicted subjects | phenotype | — | — |
| opioid dependence liability | phenotype | — | — |
| opioid-dependent individuals | phenotype | — | — |
| opioids | phenotype | — | — |
| opioid use disorder (oud) | phenotype | — | — |
| oud patients | phenotype | — | — |